Abstract
OBJECTIVE: this study has the aim to assess main aspects dealing complications in siblings of epileptic mothers with emphasis on the causes that affect high rates of fetal and neonatal morbidity and mortality.
DEVELOPMENT: malformations risks can be as high as 14%, mainly related to antiepileptic drug use during the first trimester, politherapy and to a prone genetic background. Malformations can be divided into major findings (cardiac defects, neural tube defects, genitourinary abnormalities and cleft lip / palate) and minor findings (fetal antiepileptic syndrome). Other important problems that may arise are those in psychomotor development and in learning abilities of which mechanisms are not yet clear nor the risk factors established. Finally, there is an increase of neonatal mortality, drug abstinence syndrome, hemorrhagic disorders, seizures, breast feeding problems, low birth weight and prematurity, these always associated with antiepileptics drug use.
CONCLUSIONS: despite that epilepsy during pregnancy and its treatment carry on a certain degree of complications in the sibling, these problems can be diminished once the necessary measures as prenatal council and a handling are adapted by the mother from preconceptional period and during the whole gestation.
References
Pradilla G, Vesga A, Boris E, León-Sarmiento FE. GENECO. National neuroepidemiological study in Colombia (EPINEURO). Rev Panam Salud Publica 2003; 14: 104-111.
Vélez A Eslava J. Perfil de los síndromes epilépticos y uso de anticonvulsivantes en Colombia. Bogotá: Ministerio de Salud de Colombia; 1997.
Moore SJ, Turnpenny P, Quinn A, Glover S, Lloyd DJ, Montgomery T, Dean JCS. A clinical study of 57 children with foetal anticonvulsant syndromes. J Med Gen 2000; 37: 489-497.
Gutiérrez A. Uso de anticonvulsionantes durante el embarazo y riesgo de malformaciones en el recién nacido: metanálisis. Rev Neurol 2003; 37: 1022-1028.
Penell P. The importance of monotherapy in pregnancy. Neurology 2003; 60(suppl 4): 31-38.
Ojeda G, Ordoñez M, Ochoa LH. Salud sexual y reproductiva: Resultados encuesta nacional de demografía y salud 2000. Bogotá: Asociación Probienestar de la Familia Colombiana; 2000.
Meador K Zupanc M. Neurodevelopmental outcomes of children born to mothers with epilepsy. Cleve Clin J Med 2004; 71(Supplement 2): S38 - 41.
Yerby MS. Antiepileptic Drug Use and Pregnancy. North Pacific Epilepsy Research 2001.
Holmes L Harvey E, Coull B, Huntington K, Khoshbin S, Hayes A, Ryan L. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001; 34: 1132-1138.
Yerby MS. Department of Public Health and Preventive Medicine, Cawthon ML, Office of Research and Data Analysis. Infant mortality of infants of mothers with epilepsy. North Pacific Epilepsy Research 1996.
Chang SI McAuley J. Pharmacotherapeutic issues for women of childbearing age with epilepsy. Ann Pharmacother 1998; 32: 794-801.
Dean JCS Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. British J Med Genet 2002; 39: 251-259.
Fried, S Kozer E, Nulman I, Einarson T, Koren G. Malformation rates in children of women with epilepsy.
Drug Saf 2004; 27: 197-202.
Annegers JF, Hauser W, Elveback LR, Anderson VE, Kurland LI. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Int J Epidemiol 1978; 7: 241-247.
Kaaja E Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology 2003; 60: 575-579.
Liporace JD. Women’s issues in epilepsy. Postgrad Med 1997; 102: 123-138.
Wide K Winbladh B, Källén B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on Carbamazepine and Valproic Acid: a nation-wide population- based register study. Acta Pediatr 2004; 93: 174-176.
International Database on Cranio-Facial Anomalies. A WHO - Human Genetics Programme supported project IDCFA: Project plan for any birth defects register: International Centre on Birth Defects, 2003.
Lindhout D Omtzigt J. Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age. Epilepsia 1994; 35(suppl 4): S19-S28.
Penovich PE Eck KE, Economou VV. Reco- mmendations for the care of women with epilepsy. Cleve Clin J Med 2004; 71(Suppl 2): S49-57.
Sabers A Dam M, A-Rogvi-Hansen B, Boas J, Sidenius P, Laue Friis M, Alving J, Dahl M, Ankerhus J, Mouritzen Dam A. Epilepsy and pregnancy: Lamotrigine as main drug used. Acta Neurol Scand 2004; 109: 9-13.
Gaily E. Minor anomalies and effects on psychomotor development associated with maternal use of antiepileptic drugs. In: Tomson T GL, Sillanpää M, Johannessen S, eds. Epilepsy and Pregnancy. Petersfield: Wrightson Biomedical Publishing; 1997: 63-70.
Dean JCS Moore S, Turnpenny PD. Developing diagnostic criteria for the foetal anticonvulsant syndrome. Seizure 2000; 9: 233-234.
Adab N TSC, Vinten J, Williamson P, Winterbottom J. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst Rev 2004(4).
Scolnik D, Nulman I, Rovet J, Gladstone D, et al. Neurodevelopment of children exposed in utero to Phenytoin and Carbamazepine monotherapy. JAMA 1994; 271: 767 - 770.
Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatr 2001; 70: 15-21.
Katz JM, Pacia S, Devinsky O. Current management of epilepsy and pregnancy: Fetal outcome, congenital malformations, and developmental delay. Epilepsy and Behavior 2001; 2: 119-123.
Gaily E, Kantola-Sorsa E, Granström ML. Intelligence of children of epileptic mothers. J Pediatrics 1988; 113: 667-684.
Holmes LB. The teratogenicity of anticonvulsant drugs: a progress report. J Med Gen 2002; 39: 245-247.
Hey E. Effect of maternal anticonvulsant treatment on neonatal blood coagulation. Arch Dis Child Fetal Neonatal Ed 1999; 81: 208-210.
Howe AM Oakes D, Woodman PD, Webster WS. Prothrombin and PIVKA-II levels in cord blood from newborn exposed to anticonvulsants during pregnancy. Epilepsia 1999; 40: 980-984.
Ebbesen F, Joergensen A, Hoseth E, Kaad PH, Moeller M, Holsteen V, Rix M. Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to Valproate. Arch Dis Child Fetal Neonatal 2000; 83: 124-129.
Choulika S, Grabowski E, Holmes LB. Is antenatal vitamin k prophylaxis needed for pregnant women taking anticonvulsants? Am J Obst Ginecol 2004; 190: 882-883.
Yerby MS, Kaplam P, Tran T. Risks and management of pregnancy in women with epilepsy. Cleve Clin J Med 2004; 71(suppl 2): S25-37.
Olafsson E, Hallgrimsson J, Hauser WA, Ludvigsson P, Gudmundsson G. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 1998; 39: 887-892.
Ito S. Drug therapy for breast-feeding women. N Engl J Med 2000; 343: 118-126.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.